Blog - Page 26 of 29

France Greece Netherlands Spain Switzerland USAHost-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Strategies Project type: Preclinic Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES Keywords: hospital-acquired pneumonia; pneumonology; antibiotic; infectious disease; drug resistance; biomarker; strategy; OMICs; clinical trial; procedure Countries:...

Canada France Germany Netherlands Sweden Switzerland UK USAEUbOPEN: Enabling and Unlocking biology in the OPEN

July 19, 2022by pcdata

Dates: 01/05/2020 30/04/2025 Topic: Biomarkers identification AI/Big data Project type: Preclinic Theranostic Project target: Cancer Neurology Digestive disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN Keywords: biomarker; drug; library; genome; neurodegeneration; cancer; bowel disease; solute...

SpainGenomic Data-Fusion Platform for Omics-Driven Precision Medicine

July 19, 2022by pcdata

Dates: 01/09/2020 31/08/2023 Topic: AI/Big data Project type: Preclinic Project target: Other Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION Keywords: big data; genome; OMICs; NMTF; non-negative matrix tri-factorization; platform; AI Countries: Spain Project page: Access page

SwitzerlandENERGY EFFICIENT; SPACE EFFICIENT and COST-EFFECTIVE DATA STORAGE SYSTEM FOR HEALTHCARE

July 19, 2022by pcdata

Dates: 01/07/2020 28/02/2023 Topic: AI/Big data Project type: Preclinic Project target: Other Financing: H2020-EU.2.3. – INDUSTRIAL LEADERSHIP – Innovation In SMEs MAIN PROGRAMME H2020-EU.3. – PRIORITY ‘Societal challenges H2020-EU.2.1. – INDUSTRIAL LEADERSHIP – Leadership in enabling and industrial technologies Other Participating agents: SWISS VAULT SYSTEMS GMBH Keywords: data storage; 4.0; smart cities; power; platform; green...

IrelandPredicting the effects of gut microbiota and diet on an individuals drug response and safety

July 19, 2022by pcdata

Dates: 01/04/2018 31/03/2023 Topic: Tool AI/Big data Project type: Preclinic Clinic Theranostic Project target: Neurology Colorectal Cancer Digestive disease Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: NATIONAL UNIVERSITY OF IRELAND GALWAY Keywords: nutrition; microbiote; gut; clinical trial; drug response; model; metabolism; diet; metabolit; colon cancer; Parkinson’s disease; levodopa Countries: Ireland...

ItalyEntropically programmable DNA-based bioSensors for personalized medicine

July 19, 2022by pcdata

Dates: 01/05/2021 30/04/2023 Topic: Tool Project type: Preclinic Project target: Other Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.2. – Nurturing excellence by means of cross-border and cross-sector mobility Participating agents: UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA Keywords: synthetic biology; DNA; biosensor; electronic bioengineering; bioreceptor; nanotechnology; real-time; entropic Countries: Italy Project page:...

Belgium France Germany Ireland Israel Italy Netherlands Portugal South Africa Spain Sweden Switzerland UK USAAutism Innovative Medicine Studies 2 Trials

July 19, 2022by pcdata

Dates: 01/06/2018 31/05/2023 Topic: Biomarkers identification Procedures Project type: Preclinic Clinic Project target: Neurology Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being MAIN PROGRAMME H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: KING’S COLLEGE LONDON Keywords: Autism Spectrum Disorder; clinical trial; biomarker; procedures; network; consortium Countries: UK; Switzerland; Netherlands; Spain;...

Belgium Croatia Denmark France Germany Ireland Italy Netherlands Norway Poland Portugal Spain Sweden Switzerland UKIdentification of the Molecular Mechanisms of non-response to Treatments; Relapses and Remission in Autoimmune; Inflammatory; and Allergic Conditions

July 19, 2022by pcdata

Dates: 01/09/2019 31/08/2026 Topic: Tool AI/Big Data Biomarkers identification Project type: Preclinic Clinic Guidelines Project target: Autoimmune disease Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD Keywords: systemic lupus erythematosus; rheumatoid arthritis; multiple sclerosis; asthma;...

Netherlands4D Breast Imaging for Personalized Breast Cancer Treatment

July 19, 2022by pcdata

Dates: 01/06/2020 31/05/2025 Topic: Tool Project type: Preclinic Theranostic Project target: Breast Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM Keywords: 4D; imaging; tissue; X-ray; CT; tomography; tumour; surgery; oncology; breast cancer Countries: Netherlands Project page: Access page

Portugal UKImplementation of The Discoveries Centre for Regenerative and Precision Medicine; a new Centre of Excellence in Portugal

July 19, 2022by pcdata

Dates: 01/04/2017 31/03/2024 Topic: Research centre Training Project type: Preclinic Project target: Other Financing: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions Participating agents: UNIVERSIDADE DO MINHO Keywords: monetary; finance; centre; tissue engineering; cardiovascular disease; bureaucracy; public health; regenerative Countries: Portugal; UK Project page: Access page

Newer Posts

Older Posts